These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 12606569)

  • 21. Molecular identification and characterization of peptide: N-glycanase from Schizosaccharomyces pombe.
    Xin F; Wang S; Song L; Liang Q; Qi Q
    Biochem Biophys Res Commun; 2008 Apr; 368(4):907-12. PubMed ID: 18279662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosinase degradation via two pathways during reverse translocation to the cytosol.
    Mosse CA; Hsu W; Engelhard VH
    Biochem Biophys Res Commun; 2001 Jul; 285(2):313-9. PubMed ID: 11444844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simple, sensitive in vitro assay for cytoplasmic deglycosylation by peptide: N-glycanase.
    Suzuki T
    Methods; 2005 Apr; 35(4):360-5. PubMed ID: 15804608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of proteasome inhibitors on the release into the cytosol of free polymannose oligosaccharides from glycoproteins.
    Karaivanova VK; Spiro RG
    Glycobiology; 2000 Jul; 10(7):727-35. PubMed ID: 10910976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unique peptide:N-glycanase of Caenorhabditis elegans has activity of protein disulphide reductase as well as of deglycosylation.
    Kato T; Kawahara A; Ashida H; Yamamoto K
    J Biochem; 2007 Aug; 142(2):175-81. PubMed ID: 17522090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ngly1, a mouse gene encoding a deglycosylating enzyme implicated in proteasomal degradation: expression, genomic organization, and chromosomal mapping.
    Suzuki T; Kwofie MA; Lennarz WJ
    Biochem Biophys Res Commun; 2003 May; 304(2):326-32. PubMed ID: 12711318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cytoplasmic peptide:N-glycanase (Ngly1)-basic science encounters a human genetic disorder.
    Suzuki T
    J Biochem; 2015 Jan; 157(1):23-34. PubMed ID: 25398991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-linked glycosylation does not impair proteasomal degradation but affects class I major histocompatibility complex presentation.
    Kario E; Tirosh B; Ploegh HL; Navon A
    J Biol Chem; 2008 Jan; 283(1):244-254. PubMed ID: 17951257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The retrotranslocation protein Derlin-1 binds peptide:N-glycanase to the endoplasmic reticulum.
    Katiyar S; Joshi S; Lennarz WJ
    Mol Biol Cell; 2005 Oct; 16(10):4584-94. PubMed ID: 16055502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lysosomal metabolism of glycoproteins.
    Winchester B
    Glycobiology; 2005 Jun; 15(6):1R-15R. PubMed ID: 15647514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypothesis: a glycoprotein-degradation complex formed by protein-protein interaction involves cytoplasmic peptide:N-glycanase.
    Suzuki T; Lennarz WJ
    Biochem Biophys Res Commun; 2003 Feb; 302(1):1-5. PubMed ID: 12593838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A complex between peptide:N-glycanase and two proteasome-linked proteins suggests a mechanism for the degradation of misfolded glycoproteins.
    Katiyar S; Li G; Lennarz WJ
    Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13774-9. PubMed ID: 15358861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yeast N-glycanase distinguishes between native and non-native glycoproteins.
    Hirsch C; Misaghi S; Blom D; Pacold ME; Ploegh HL
    EMBO Rep; 2004 Feb; 5(2):201-6. PubMed ID: 14726951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Free-oligosaccharide control in the yeast Saccharomyces cerevisiae: roles for peptide:N-glycanase (Png1p) and vacuolar mannosidase (Ams1p).
    Chantret I; Frénoy JP; Moore SE
    Biochem J; 2003 Aug; 373(Pt 3):901-8. PubMed ID: 12723970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Checkpoints in ER-associated degradation: excuse me, which way to the proteasome?
    Ahner A; Brodsky JL
    Trends Cell Biol; 2004 Sep; 14(9):474-8. PubMed ID: 15350974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-proteasomal antigen processing for major histocompatibility complex class I presentation.
    Rock KL; York IA; Goldberg AL
    Nat Immunol; 2004 Jul; 5(7):670-7. PubMed ID: 15224092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amino acid composition of alpha1/alpha2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated down-regulation.
    Barel MT; Pizzato N; van Leeuwen D; Bouteiller PL; Wiertz EJ; Lenfant F
    Eur J Immunol; 2003 Jun; 33(6):1707-16. PubMed ID: 12778489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytoplasmic peptide:N-glycanase and catabolic pathway for free N-glycans in the cytosol.
    Suzuki T
    Semin Cell Dev Biol; 2007 Dec; 18(6):762-9. PubMed ID: 17950635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Neurospora peptide:N-glycanase ortholog PNG1 is essential for cell polarity despite its lack of enzymatic activity.
    Maerz S; Funakoshi Y; Negishi Y; Suzuki T; Seiler S
    J Biol Chem; 2010 Jan; 285(4):2326-32. PubMed ID: 19940117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The occurrence of nonglycosylated forms of N-glycoprotein upon proteasome inhibition does not confirm cytosolic deglycosylation.
    Huang C; Suzuki T
    FEBS Lett; 2020 May; 594(9):1433-1442. PubMed ID: 31951015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.